Alternatively, varied microenvironmental cues may differentially modulate the expression of β4 integrin and FAK in patients with breast cancer, as indicated by the differences displayed in luminal A, luminal B, HER2+, and TNBC (Fig. 6a). The gene discussed is PTK2; the disease is breast carcinoma.